Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (jcs 2008)

Circulation Journal

Volumn 74, Issue 8, 2010, Pages 1745-1762

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CALMODULIN; CORTICOSTEROID DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN DERIVATIVE; FASUDIL; INSULIN; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; NICORANDIL; NITRATE;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; AUTONOMIC NEUROPATHY; CIGARETTE SMOKING; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SPASM; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRINKING BEHAVIOR; ELECTROCARDIOGRAM; EXERCISE TEST; HEREDITY; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RACE DIFFERENCE; TAKOTSUBO CARDIOMYOPATHY;

ANGINA PECTORIS; CORONARY VASOSPASM; DISEASE MANAGEMENT; HUMANS; MYOCARDIAL INFARCTION;

EID: 77955059326     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-74-0802     Document Type: Article

References (227)

1. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: A review. Circ Res 1983; 52: I-147-I-152.
2. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 1989; 80: 1617-1626.
3. Soejima H, Irie A, Miyamoto S, Kajiwara I, Kojima S, Hokamaki J, et al. Preference toward a T-helper type 1 response in patients with coronary spastic angina. Circulation 2003; 107: 2196-2200.
4. Yasue H, Kugiyama K. Coronary artery spasm: Japanese view. Coron Artery Dis 1990; 1: 668-673.
5. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994; 23: 352-357.
6. Vandergoten P, Benit E, Dendale P. Prinzmetal's variant angina: Three case reports and a review of the literature. Acta Cardiol 1999; 54: 71-76.
7. Suzuki H, Kawai S, Aizawa T, Kato K, Sunayama S, Okada R, et al. Histological evaluation of coronary plaque in patients with variant angina: Relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol 1999; 33: 198-205.
8. Ozaki Y, Keane D, Serruys PW. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. Circulation 1995; 92: 2446-2456.
9. Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, et al. Progression of coronary atherosclerosis: Is coronary spasm related to progression? J Am Coll Cardiol 1991; 18: 904-910.
10. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-134.
11. Lin CS, Penha PD, Zak FG, Lin JC. Morphodynamic interpretation of acute coronary thrombosis, with special reference to volcano-like eruption of atheromatous plaque caused by coronary artery spasm. Angiology 1988; 39: 535-547.
12. Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K. Fibrinopeptide A is released into the coronary circulation after coronary spasm. Circulation 1990; 82: 2222-2225.
13. Misumi I, Ogawa H, Masuda T, Sakamoto T, Okumura K, Yasue H. Increased plasma plasminogen activator inhibitor activity after coronary spasm. Int J Cardiol 1993; 41: 21-29.
14. Kaikita K, Ogawa H, Yasue H, Sakamoto T, Suefuji H, Okumura K. Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92: 1726-1730.
15. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008; 51: 2-17.
16. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986; 74: 955-963.
17. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, et al. Sensitivity and specifcity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12: 883-888.
18. Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, et al. Multivessel coronary spasm in patients with variant angina: A study with intracoronary injection of acetylcho-line. Circulation 1988; 77: 535-542.
19. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 1999; 83: 1186-1190.
20. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-79.
21. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and infuential factors. Circulation 1988; 78: 1-9.
22. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Y, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: Role of cigarette smoking. Int J Cardiol 2000; 72: 121-126.
23. Yasue H, Kugiyama K. Coronary artery spasm-Clinical features, pathogenesis and treatment. In: Yasue H, editor. Coronary artery spasm. Tokyo: Axel Springer Japan Publishing Inc, 2000; 9-18.
24. Miwa K, Fujita M, Miyagi Y. Beneficial effects of smoking cessation on the short-term prognosis for variant angina-validation of the smoking status by urinary cotinine measurements. Int J Cardiol 1994; 44: 151-156.
25. Goto K, Yasue H, Okumura K, Matsuyama K, Kugiyama K, Miyagi H, et al. Magnesium deficiency detected by intravenous loading test in variant angina pectoris. Am J Cardiol 1990; 65: 709-712.
26. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 1989; 79: 597-602.
27. Shimabukuro M, Shinzato T, Higa S, Chibana T, Yoshida H, Nagamine F, et al. Enhanced insulin response relates to acetyl-choline-induced vasoconstriction in vasospastic angina. J Am Coll Cardiol 1995; 25: 356-361.
28. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, et al. Insulin resistance associated with compensatory hyperin-sulinemia as an independent risk factor for vasospastic angina. Circulation 1995; 92: 1749-1757.
29. Suzuki M, Nishizaki M, Arita M, Kakuta T, Numano F. Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina. J Am Coll Cardiol 1996; 27: 1458-1463.
30. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974; 50: 534-539.
31. Miwa K, Igawa A, Miyagi Y, Nakagawa K, Inoue H. Alterations of autonomic nervous activity preceding nocturnal variant angina: Sympathetic augmentation with parasympathetic impairment. Am Heart J 1998; 135: 762-771.
32. Ooie T, Takakura T, Shiraiwa H, Yoshimura A, Hara M, Saikawa T. Change in heart rate variability preceding ST elevation in a patient with vasospastic angina pectoris. Heart Vessels 1998; 13: 40-44.
33. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is defcient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-271.
34. -786 → C mutation in the 5'-fanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.
35. -786 → C mutation in the 5'-fanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 2000; 86: 628-634.
36. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a-786T → C mutation associated with coronary spastic angina. Hum Mol Genet 2000; 9: 2629-2637.
37. -786 → C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. Pharmacogenetics 2003; 13: 683-688.
38. Nishijima T, Nakayama M, Yoshimura M, Abe K, Yamamuro M, Suzuki S, et al. The endothelial nitric oxide synthase gene-786T/ C polymorphism is a predictive factor for reattacks of coronary spasm. Pharmacogenet Genomics 2007; 17: 581-587.
39. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41-45.
40. -786 → C and missense Glu298Asp variants. J Investig Med 2000; 48: 367-374.
41. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001; 11: 719-725.
42. Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K. Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm. Circulation 2002; 105: 2024-2029.
43. Okumura K, Osanai T, Kosugi T, Hanada H, Ishizaka H, Fukushi T, et al. Enhanced phospholipase C activity in the cultured skin fbroblast obtained from patients with coronary spastic angina: Possible role for enhanced vasoconstrictor response. J Am Coll Cardiol 2000; 36: 1847-1852.
44. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M, et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004; 25: 970-977.
45. Yasue H, Sasayama S, Kikuchi K, Okumura K, Matsubara T, Miwa K, et al. The study on the role of coronary spasm in ischemic heart disease. In: Annual report of the research on cardiovascular diseases. Osaka: National Cardiovascular Center, 2000; 96-97 (in Japanese).
46. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982; 65: 1299-1306.
47. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 2004; 55: 403-411.
48. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 1987; 75: 1110-1116.
49. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long-term prognosis of patients with variant angina: A comparative study between western and Japanese populations. Int J Cardiol 1988; 18: 331-349.
50. Severi S, Davies G, Maseri A, Marzullo P, L'Abbate A. Long-term prognosis of "variant" angina with medical treatment. Am J Cardiol 1980; 46: 226-232.
51. Waters DD, Miller DD, Szlachcic J, Bouchard A, Méthé M, Kreeft J, et al. Factors infuencing the long-term prognosis of treated patients with variant angina. Circulation 1983; 68: 258-265.
52. Mark DB, Califf RM, Morris KG, Harrell FE Jr, Pryor DB, Hlatky MA, et al. Clinical characteristics and long-term survival of patients with variant angina. Circulation 1984; 69: 880-888.
53. Walling A, Waters DD, Miller DD, Roy D, Pelletier GB, Théroux P. Long-term prognosis of patients with variant angina. Circulation 1987; 76: 990-997.
54. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FA, Delforge MG, Chahine RA. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. Eur Heart J 1983; 4: 532-535.
55. Mongiardo R, Finocchiaro ML, Beltrame J, Pristipino C, Lombardo A, Cianfone D, et al. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent myocardial infarction. Am J Cardiol 1996; 78: 84-87.
56. Okumura K, Yasue H, Matsuyama K, Ogawa H, Morikami Y, Obata K, et al. Effect of acetylcholine on the highly stenotic coronary artery: Difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery. J Am Coll Cardiol 1992; 19: 752-758.
57. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-1452.
58. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
59. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
60. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
61. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.
62. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
63. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizaka H, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina: Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitro-glycerin. J Am Coll Cardiol 1996; 27: 45-52.
64. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: Lessons from animal models. Jpn Circ J 2000; 64: 1-12.
65. Katsumata N, Shimokawa H, Seto M, Kozai T, Yamawaki T, Kuwata K, et al. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. Circulation 1997; 96: 4357-4363.
66. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev 1996; 76: 967-1003.
67. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, et al. Regulation of myosin phosphatase by Rho and Rho-associ-ated kinase (Rho-kinase). Science 1996; 273: 245-248.
68. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996; 271: 20246-20249.
69. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
70. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A Jr, et al. ACC/AHA guidelines for ambulatory elec-trocardiography: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation 1999; 100: 886-893.
71. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I: A variant form of angina pector. preliminary report. Am J Med 1959; 27: 375-388.
72. Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Araki H, Nakamura M, et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science 1983; 221: 560-562.
73. Waters DD, Szlachcic J, Bourassa MG, Scholl JM, Théroux P. Exercise testing in patients with variant angina: Results, correlation with clinical and angiographic features and prognostic significance. Circulation 1982; 65: 265-274.
74. Rovai D, Distante A, Moscarelli E, Morales MA, Picano E, Palombo C, et al. Transient myocardial ischemia with minimal electro cardiographic changes: An echocardiographic study in patients with Prinzmetal's angina. Am Heart J 1985; 109: 78-83.
75. De Servi S, Falcone C, Gavazzi A, Mussini A, Bramucci E, Curti MT, et al. The exercise test in variant angina: Results in 114 patients. Circulation 1981; 64: 684-688.
76. Castello R, Alegria E, Merino A, Fidalgo ML, Martinez-Caro D. The value of exercise testing in patients with coronary artery spasm. Am Heart J 1990; 119: 259-263.
77. De Servi S, Specchia G, Angoli L. Coronary artery spasm of different degrees as cause of angina at rest with ST segment depression and elevation. Br Heart J 1979; 42: 110-112.
78. Weiner DA, Schick EC Jr, Hood WB Jr, Ryan TJ. ST-segment elevation during recovery from exercise: A new manifestation of Prinzmetal's variant angina. Chest 1978; 74: 133-138.
79. Scardi S, Pivotti F, Pandullo C, Ceschia G, Salvi A. Exercise-induced intermittent angina and ST-segment elevation in Prinzmetal's angina. Eur Heart J 1988; 9: 102-105.
80. Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978; 58: 56-62.
81. Fujii H, Yasue H, Okumura K, Matsuyama K, Morikami Y, Miyagi H, et al. Hyperventilation-induced simultaneous multives-sel coronary spasm in patients with variant angina: An echocar-diographic and arteriographic study. J Am Coll Cardiol 1988; 12: 1184-1192.
82. Nakao K, Ohgushi M, Yoshimura M, Morooka K, Okumura K, Ogawa H, et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 1997; 80: 545-549.
83. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol 1989; 63: 17-20.
84. Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986; 74: 1255-1265.
85. Girotti LA, Crosatto JR, Messuti H, Kaski JC, Dyszel E, Rivas CA, et al. The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. Am J Cardiol 1982; 49: 834-841.
86. Takaoka K, Yasue H, Horio Y. Possible role of coronary spasm in acute myocardial infarction precipitated by hyperventilation. Br Heart J 1988; 59: 256-258.
87. Sueda S, Saeki H, Otani T, Ochi N, Kukita H, Kawada H, et al. Investigation of the most effective provocation test for patients with coronary spastic angina: Usefulness of accelerated exercise following hyperventilation. Jpn Circ J 1999; 63: 85-90.
88. Sueda S, Hashimoto H, Ochi N, Hayashi Y, Kawada H, Tsuruoka T, et al. New protocol to detect coronary spastic angina without fxed stenosis. Jpn Heart J 2002; 43: 307-317.
89. Shanoudy H, Raggi P, Gasperetti C, Soliman A, Ramachandran K, Ammerman GE, et al. Detection of coronary vasospasm by posthyperventilation technetium-99m sestamibi single-photon emission computed tomography imaging in patients with coronary artery disease. Am J Cardiol 1998; 81: 573-577.
90. Hirano Y, Ozasa Y, Yamamoto T, Uehara H, Yamada S, Nakagawa K, et al. Hyperventilation and cold-pressor stress echocardiogra-phy for noninvasive diagnosis of coronary artery spasm. J Am Soc Echocardiogr 2001; 14: 626-633.
91. Hirano Y, Ozasa Y, Yamamoto T, Nakagawa K, Uehara H, Yamada S, et al. Diagnosis of vasospastic angina by hyperventilation and cold-pressor stress echocardiography: Comparison to I-MIBG myocardial scintigraphy. J Am Soc Echocardiogr 2002; 15: 617-623.
92. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 1672-1679.
93. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
94. Yoshida T, Kawano H, Miyamoto S, Motoyama T, Fukushima H, Hirai N, et al. Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. Intern Med 2006; 45: 575-579.
95. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent fow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
96. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduct arteries in vivo. Circulation 1995; 91: 1314-1319.
97. Kawano H, Motoyama T, Yasue H, Hirai N, Waly HM, Kugiyama K, et al. Endothelial function fuctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. J Am Coll Cardiol 2002; 40: 266-270.
98. Kawano H, Motoyama T, Ohgushi M, Kugiyama K, Ogawa H, Yasue H. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 2001; 135: 977-981.
99. Ito K, Akita H, Kanazawa K, Yamada S, Shiga N, Terashima M, et al. Systemic endothelial function is preserved in men with both active and inactive variant angina pectoris. Am J Cardiol 1999; 84: 1347-1349, A8.
100. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-1006.
101. Moriyama Y, Tsunoda R, Harada M, Miyao Y, Yoshimura M, Kugiyama K, et al. Nitric oxide-mediated vasodilatation is decreased in forearm resistance vessels in patients with coronary spastic angina. Jpn Circ J 2001; 65: 81-86.
102. Shanes JG, Pavel D, Blend M, Olea E, Krone R, Lacny K, et al. Comparison of electrocardiography and thallium-201 myocardial scintigraphy for the detection of ergonovine-induced coronary artery spasm: Angiographic correlation. Am Heart J 1987; 113: 663-671.
103. Aoki M, Koyanagi S, Sakai K, Irie T, Takeshita A, Nakamura M, et al. Exercise-induced silent myocardial ischemia in patients with vasospastic angina. Am Heart J 1990; 119: 551-556.
104. Motomura K, Kugiyama K, Yasue H, Minoda K, Okumura K, Inobe Y, et al. Infuence of exercise-induced coronary artery spasm on thallium-201 initial distribution and washout kinetics in patients with variant and classic angina pectoris. Am J Cardiol 1994; 73: 661-665.
105. Sakata K, Yoshida H, Sugino H, Iimuro M, Matsunaga Y, Ono N, et al. Assessment of quantitative exercise thallium-201 emission computed tomography in patients with vasospastic angina-value of washout rate analysis. Jpn Circ J 1994; 58: 379-388.
106. Masuoka T, Ajisaka R, Watanabe S, Yamanouchi T, Iida K, Sato M, et al. Usefulness of hyperventilation thallium-201 single photon emission computed tomography for the diagnosis of vasospastic angina. Jpn Heart J 1995; 36: 405-420.
107. Minoda K, Yasue H, Kugiyama K, Okumura K, Motomura K, Shimomura O, et al. Comparison of the distribution of myocardial blood fow between exercise-induced and hyperventilation-induced attacks of coronary spasm: A study with thallium-201 myocardial scintigraphy. Am Heart J 1994; 127: 1474-1480.
108. Takano H, Nakamura T, Satou T, Umetani K, Watanabe A, Ishihara T, et al. Regional myocardial sympathetic dysinnervation in patients with coronary vasospasm. Am J Cardiol 1995; 75: 324-329.
109. Sakata K, Miura F, Sugino H, Saegusa T, Shirotani M, Yoshida H, et al. Assessment of regional sympathetic nerve activity in vaso-spastic angina: Analysis of iodine 123-labeled metaiodobenzyl-guanidine scintigraphy. Am Heart J 1997; 133: 484-489.
110. Inobe Y, Kugiyama K, Miyagi H, Ohgushi M, Tomiguchi S, Takahashi M, et al. Long-lasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: Quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy. Am Heart J 1997; 134: 112-118.
111. Taki J, Yasuhara S, Takamatsu T, Nakajima K, Tatami R, Ishise S, et al. Value of iodine-123 metaiodobenzylguanidine scintigraphy in patients with vasospastic angina. Eur J Nucl Med 1998; 25: 229-234.
112. Ha JW, Lee JD, Jang Y, Chung N, Kwan J, Rim SJ, et al. 123I-MIBG myocardial scintigraphy as a noninvasive screen for the diagnosis of coronary artery spasm. J Nucl Cardiol 1998; 5: 591-597.
113. Sakata K, Iida K, Kudo M, Yoshida H, Doi O. Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without signifcant coronary stenosis. Circ J 2005; 69: 171-176.
114. Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995; 36: 1934-1940.
115. Watanabe K, Ohta Y, Toba K, Ogawa Y, Aizawa Y, Tanabe N, et al. Abnormal fatty acid metabolism in patients with coronary vaso-spasm. Ann Nucl Med 1999; 13: 33-41.
116. Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Oates JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979; 59: 637-643.
117. Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988; 77: 43-52.
118. Antony I, Aptecar E, Lerebours G, Nitenberg A. Coronary artery constriction caused by the cold pressor test in human hypertension. Hypertension 1994; 24: 212-219.
119. Macho P, Hintze TH, Vatner SF. Regulation of large coronary arteries by increases in myocardial metabolic demands in conscious dogs. Circ Res 1981; 49: 594-599.
120. Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilatation in humans. Circulation 1989; 80: 466-474.
121. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991; 88: 1663-1671.
122. Previtali M, Ardissino D, Storti C, Chimienti RD, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal's variant angina: Comparative sensitivity and relation with the activity of the disease. Eur Heart J 1989; 10(Suppl F): 101-104.
123. Crea F, Davies G, Chierchia S, Romeo F, Bugiardini R, Kaski JC, et al. Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. Am J Cardiol 1985; 56: 18-22.
124. Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, et al. Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations. Circulation 1980; 62: 925-932.
125. Shimizu H, Lee JD, Yamamoto M, Satake K, Tsubokawa A, Kawasaki N, et al. Induction of coronary artery spasm by combined cold pressor and hyperventilation test in patients with variant angina. J Cardiol 1994; 24: 257-261 (in Japanese).
126. Strike PC, Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J 2003; 24: 690-703.
127. Yoshida K, Utsunomiya T, Morooka T, Yazawa M, Kido K, Ogawa T, et al. Mental stress test is an effective inducer of vaso-spastic angina pectoris: Comparison with cold pressor, hyperventilation and master two-step exercise test. Int J Cardiol 1999; 70: 155-163.
128. Cannon CP, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Zipes DP, Libby PBRO, Braunwald E, editors. Braunwald's heart disease. A textbook of cardiovascular medicine, 7th edn. Philadelphia: WB Saunders, 2005; 1243-1279.
129. Sueda S, Izoe Y, Kohno H, Fukuda H, Uraoka T. Need for documentation of guidelines for coronary artery spasm: An investigation by questionnaire in Japan. Circ J 2005; 69: 1333-1337.
130. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987; 75: 577-582.
131. Curry RC Jr, Pepine CJ, Sabom MB, Conti CR. Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation 1979; 59: 307-312.
132. Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, et al. Refractory ergonovine-induced coronary vasospasm: Importance of intracoronary nitroglycerin. Am J Cardiol 1980; 46: 329-334.
133. Harding MB, Leithe ME, Mark DB, Nelson CL, Harrison JK, Hermiller JB, et al. Ergonovine maleate testing during cardiac catheterization: A 10-year perspective in 3,447 patients without signifcant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol 1992; 20: 107-111.
134. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, et al. Induction of coronary artery spasm by two pharmacological agents: Comparison between intracoronary injection of acetyl choline and ergonovine. Coron Artery Dis 2003; 14: 451-457.
135. Horimoto M, Igarashi K, Takenaka T, Inoue H, Yamazaki K, Sakuragi H. Acetylcholine- and ergonovine-induced coronary micro vascular spasm reflected by increased coronary vascular resistance and myocardial lactate production. Clin Cardiol 2000; 23: 221-225.
136. Matsuyama K, Yasue H, Okumura K, Saito Y, Nakao K, Shirakami G, et al. Increased plasma level of endothelin-1-like immuno reactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 1991; 68: 991-995.
137. Goldberg S, Lam W, Mudge G, Green LH, Kushner F, Hirshfeld JW, et al. Coronary hemodynamic and myocardial metabolic alterations accompanying coronary spasm. Am J Cardiol 1979; 43: 481-487.
138. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary micro-vascular spasm. Lancet 1998; 351: 1165-1169.
139. Mizuno K, Miyamoto A, Satomura K, Kurita A, Arai T, Sakurada M, et al. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337: 809-812.
140. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, et al. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992; 326: 287-291.
141. Etsuda H, Mizuno K, Arakawa K, Satomura K, Shibuya T, Isojima K. Angioscopy in variant angina: Coronary artery spasm and intimal injury. Lancet 1993; 342: 1322-1324.
142. Miyao Y, Kugiyama K, Kawano H, Motoyama T, Ogawa H, Yoshimura M, et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 2000; 36: 432-437.
143. Hong MK, Park SW, Lee CW, Ko JY, Kang DH, Song JK, et al. Intravascular ultrasound fndings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina. Am Heart J 2000; 140: 395-401.
144. Saito S, Yamagishi M, Takayama T, Chiku M, Koyama J, Ito K, et al. Plaque morphology at coronary sites with focal spasm in variant angina: Study using intravascular ultrasound. Circ J 2003; 67: 1041-1045.
145. Koyama J, Yamagishi M, Tamai J, Kawano S, Daikoku S, Miyatake K. Comparison of vessel wall morphologic appearance at sites of focal and diffuse coronary vasospasm by intravascular ultrasound. Am Heart J 1995; 130: 440-445.
146. Koizumi T, Yokoyama M, Namikawa S, Kuriyama N, Nameki M, Nakayama T, et al. Location of focal vasospasm provoked by ergonovine maleate within coronary arteries in patients with vasospastic angina pectoris. Am J Cardiol 2006; 97: 1322-1325.
147. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-1108.
148. Miwa K, Igawa A, Miyagi Y, Fujita M. Importance of magnesium defciency in alcohol-induced variant angina. Am J Cardiol 1994; 73: 813-816.
149. Takizawa A, Yasue H, Omote S, Nagao M, Hyon H, Nishida S, et al. Variant angina induced by alcohol ingestion. Am Heart J 1984; 107: 25-27.
150. Kawano H, Soejima H, Kojima S, Kitagawa A, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ J 2006; 70: 513-517.
151. Nobuyoshi M, Abe M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, et al. Statistical analysis of clinical risk factors for coronary artery spasm: Identifcation of the most important determinant. Am Heart J 1992; 124: 32-38.
152. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 1992; 85: 905-909.
153. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol 1994; 24: 546-554.
154. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334: 150-154.
155. Gordon T, Kannel WB, McGee D, Dawber TR. Death and coronary attacks in men after giving up cigarette smoking: A report from the Framingham study. Lancet 1974; 2: 1345-1348.
156. Kannel WB. Prevention of heart disease in the young coronary candidate. Prim Care 1977; 4: 229-243.
157. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials. JAMA 1996; 275: 1590-1597.
158. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
159. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, Kugiyama K, et al. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: Possible role of reactive oxygen species. J Am Coll Cardiol 2000; 35: 1860-1866.
160. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al; American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Rehabilitation, and Prevention; American Heart Association Council on Nutrition, Physical Activity, and Metabolism Subcommittee on Physical Activity. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107: 3109-3116.
161. Mizuno Y, Yasue H, Harada E, Ito T, Nakayama M, Yoshimura M. Recurrence of coronary spasm after withdrawal of Ca-antagonists-suppression by an HMG Co-A reductase Inhibitor. Circulation 2006; 114: II-599.
162. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-21.
163. Kugiyama K, Ohgushi M, Sugiyama S, Motoyama T, Kawano H, Hirashima O, et al. Supersensitive dilator response to nitroglycerin but not to a trial natriuretic peptide in spastic coronary arteries in coronary spastic angina. Am J Cardiol 1997; 79: 606-610.
164. Carter RW, Begaye M, Kanagy NL. Acute and chronic NOS inhibition enhances alpha(2)- adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. Am J Physiol Heart Circ Physiol 2002; 283: H1361-H1369.
165. Antman E, Muller J, Goldberg S, MacAlpin R, Rubenfre M, Tabatznik B, et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med 1980; 302: 1269-1273.
166. Kimura E, Kishida H. Treatment of variant angina with drugs: A survey of 11 cardiology institutes in Japan. Circulation 1981; 63: 844-848.
167. Ginsburg R, Lamb IH, Schroeder JS, Hu M, Harrison DC. Randomized double-blind comparison of nifedipine and isosor-bide dinitrate therapy in variant angina pectoris due to coronary artery spasm. Am Heart J 1982; 103: 44-49.
168. Mauritson DR, Johnson SM, Winniford MD, Cary JR, Willerson JT, Hillis LD. Verapamil for unstable angina at rest: A short-term randomized, double-blind study. Am Heart J 1983; 106: 652-658.
169. Pesola A, Lauro A, Gallo R, Madeo A, Cosentino G. Efficacy of diltiazem in variant angina: Results of a doubleblind crossover study in CCU by Holter monitoring. The possible occurrence of a withdrawal syndrome. G Ital Cardiol 1987; 17: 329-339.
170. Chahine RA, Feldman RL, Giles TD, Nicod P, Raizner AE, Weiss RJ, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina: Amlodipine Study 160 Group. J Am Coll Cardiol 1993; 21: 1365-1370.
171. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480-485.
172. Tashiro H, Shimokawa H, Koyanagi S, Takeshita A. Clinical characteristics of patients with spontaneous remission of variant angina. Jpn Circ J 1993; 57: 117-122.
173. Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, et al. Effect of nicorandil on coronary spasm. Am J Cardiol 1989; 63: 75J-79J.
174. Furukawa K, Itoh T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, et al. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 1981; 218: 248-259.
175. Imai S, Ushijima T, Nakazawa M, Nabata H, Sakai K. Mechanism of relaxant effects of nicorandil on the dog coronary artery. Arch Int Pharmacodyn Ther 1983; 265: 274-282.
176. Itoh T, Furukawa K, Kajiwara M, Kitamura K, Suzuki H, Ito Y, et al. Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries. J Pharmacol Exp Ther 1981; 218: 260-270.
177. Araki H, Hayata N, Matsuguchi T, Nakamura M. Effects of nicor-andil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate. Clin Ther 1987; 9: 174-182.
178. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, et al. Usefulness of massive oral nicorandil in a patient with variant angina refractory to conventional treatment. Intern Med 2003; 42: 163-167.
179. Noguchi T, Nonogi H, Yasuda S, Daikoku S, Morii I, Itoh A, et al. Refractory coronary spasm relieved by intracoronary administration of nicorandil. Jpn Circ J 2000; 64: 396-398.
180. Uchida Y, Yoshimoto N, Murao S. Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation. Jpn Heart J 1978; 19: 112-124.
181. Miwa K, Miyagi Y, Fujita M. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol 1995; 26: 632-638.
182. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E defciency in variant angina. Circulation 1996; 94: 14-18.
183. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 2003; 26: 177-181.
184. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 103-109.
185. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: Possible role of early coronary atherosclerosis. Circulation 1990; 81: 482-490.
186. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfeld JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24: 471-476.
187. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-1510.
188. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
189. Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M, et al. Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: Possible role of estrogen and nitric oxide. Proc Assoc Am Physicians 1996; 108: 473-480.
190. Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Fujii H, et al. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997; 30: 914-919.
191. Kawano H, Motoyama T, Hirai N, Kugiyama K, Ogawa H, Yasue H. Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina. J Am Coll Cardiol 2001; 37: 735-740.
192. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefts of estrogen plus proges-tin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
193. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-613.
194. Hoch FL. Thyrotoxicosis as a disease of mitochondria. N Engl J Med 1962; 266: 498-505.
195. Tai PC, Hayes DJ, Clark JB, Spry CJ. Toxic effects of human eosinophil products on isolated rat heart cells in vitro. Biochem J 1982; 204: 75-80.
196. Egashira K, Tomoike H, Yamamoto Y, Yamada A, Hayashi Y, Nakamura M. Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: Roles of serum cholesterol and spontaneous or induced intimal thickening. Circulation 1986; 74: 826-837.
197. Okada H, Koganei H, Yoshioka S, Enta K, Suzuki K, Kato J, et al. Multi-vasospastic angina refractory to medical therapy caused by hyperthyroid stage of chronic thyroiditis and hypereosinophilia: A case report. J Cardiol 2000; 35: 189-196 (in Japanese).
198. Takagi S, Goto Y, Hirose E, Terashima M, Sakuragi S, Suzuki S, et al. Successful treatment of refractory vasospastic angina with corticosteroids: Coronary arterial hyperactivity caused by local infammation? Circ J 2004; 68: 17-22.
199. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545-1547.
200. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999; 43: 1029-1039.
201. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Eto Y, Morishige K, et al. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arterioscler Thromb Vasc Biol 2003; 23: 2209-2214.
202. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocar-dial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003; 41: 15-19.
203. Inokuchi K, Ito A, Fukumoto Y, Matoba T, Shiose A, Nishida T, et al. Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery. J Cardiovasc Pharmacol 2004; 44: 275-277.
204. Tanabe Y, Itoh E, Suzuki K, Ito M, Hosaka Y, Nakagawa I, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol 2002; 39: 1120-1126.
205. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, et al. Sirolimus-eluting stents associated with para-doxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46: 231-236.
206. Corcos T, David PR, Bourassa MG, Val PG, Robert J, Mata LA, et al. Percutaneous transluminal coronary angioplasty for the treatment of variant angina. J Am Coll Cardiol 1985; 5: 1046-1054.
207. Bertrand ME, LaBlanche JM, Thieuleux FA, Fourrier JL, Traisnel G, Asseman P. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fxed coronary stenosis. J Am Coll Cardiol 1986; 8: 504-508.
208. Prinzmetal M, Ekmekci A, Kennamer R, Kwoczynski JK, Shubin H, Toyoshima H. Variantform of angina pectoris, previously unde-lineated syndrome. JAMA 1960; 174: 1794-1800.
209. MacAlpin RN. Relation of coronary arterial spasm to sites of organic stenosis. Am J Cardiol 1980; 46: 143-153.
210. Study of the role of coronary spasm in ischemic heart disease, supported by grants for studies on cardiovascular diseases from the Ministry of Health, Labor, and Welfare (MHLW) (10ko-5). Research report in 2000 (in Japanese).
211. Meisel SR, Mazur A, Chetboun I, Epshtein M, Canetti M, Gallimidi J, et al. Usefulness of implantable cardioverter-defibrilla-tors in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically nomal coronary arteries. Am J Cardiol 2002; 89: 1114-1116.
212. Chevalier P, Dacosta A, Defaye P, Chalvidan T, Bonnefoy E, Kirkorian G, et al. Arrhythmic cardiac arrest due to isolated coronary artery spasm: Long-term outcome of seben resuscitated patients. J Am Coll Cardiol 1998; 31: 57-61.
213. Saitoh S, Onogi F, Aikawa K, Muto M, Saito T, Maehara K, et al. Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A2. J Am Coll Cardiol 2001; 37: 308-315.
214. Hanet C, Robert A, Wijns W. Vasomotor response to ergometrine and nitrates of saphenous vein grafts, internal mammary artery grafts, and grafted coronary arteries late after bypass surgery. Circulation 1992; 86: II-210-II-216.
215. He GW. Arterial grafts for coronary surgery: Vasospasm and patency rate. J Thorac Cardiovasc Surg 2001; 121: 431-433.
216. Satoh H, Tateishi H, Uchida T, Dote K, Ishihara M. Stunned myocardium with specifc (tsubo-type) left ventriculographic confgu-ration due to multivessel spasm. In: Kodama K, Haze K, Hori M, editors. Clinical aspect of myocardial injury: from ischemia to heart failure. Tokyo: Kagaku Hyoron-sya Co, 1990; 56-64 (in Japanese).
217. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: A review of 5 cases. J Cardiol 1991; 21: 203-214 (in Japanese).
218. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al; Angina Pectoris-Myocardial Infarction Investigations in Japan. Transient left ventricular apical ballooning without coronary artery stenosis: A novel heart syndrome mimicking acute myocardial infarction: Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol 2001; 38: 11-18.
219. Kawai S, Suzuki H, Yamaguchi H, Tanaka K, Sawada H, Aizawa T, et al. Ampulla cardiomyopathy (Takotsubo cardiomyopathy): Reversible left ventricular dysfunction with ST segment elevation. Jpn Circ J 2000; 64: 156-159.
220. Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: A novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002; 143: 448-455.
221. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003; 41: 737-742.
222. Pavin D, Le Breton H, Daubert C. Human stress cardiomyopathy mimicking acute myocardial syndrome. Heart 1997; 78: 509-511.
223. Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. Chest 1998; 114: 98-105.
224. Desmet WJ, Adriaenssens BF, Dens JA. Apical ballooning of the left ventricle: First series in white patients. Heart 2003; 89: 1027-1031.
225. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: Transient left ventricular apical ballooning: A syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004; 141: 858-865.
226. Brandspiegel HZ, Marinchak RA, Rials SJ, Kowey PR. A broken heart. Circulation 1998; 98: 1349.
227. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352: 539-548.